Paper40573239
Natural Nanoparticles for Drug Delivery: Proteomic Insights and Anticancer Potential of Doxorubicin-Loaded Avocado Exosomes.
Salem D and 9 others. Pharmaceuticals (Basel), 2025. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. Natural Nanoparticles for Drug Delivery: Proteomic Insights and Anticancer Potential of Doxorubicin-Loaded Avocado Exosomes. Papers, record 40573239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40573239
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Natural Nanoparticles for Drug Delivery: Proteomic Insights and Anticancer Potential of Doxorubicin-Loaded Avocado Exosomes.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36519808 | Plant-derived extracellular vesicles: Recent advancements and current challenges on their use for biomedical applications. | J Extracell Vesicles | 2022 | https://conductscience.org/library/papers/36519808 | PubMed |
| 2 | 38884850 | A comprehensive review on doxorubicin: mechanisms, toxicity, clinical trials, combination therapies and nanoformulations in breast cancer. | Drug Deliv Transl Res | 2025 | https://conductscience.org/library/papers/38884850 | PubMed |
| 3 | 35804089 | Bioinformatics analysis of the role of aldolase A in tumor prognosis and immunity. | Sci Rep | 2022 | https://conductscience.org/library/papers/35804089 | PubMed |
| 4 | 34930289 | Aloe derived nanovesicle as a functional carrier for indocyanine green encapsulation and phototherapy. | J Nanobiotechnology | 2021 | https://conductscience.org/library/papers/34930289 | PubMed |
| 5 | 34496230 | Exosomes as mediators of intercellular crosstalk in metabolism. | Cell Metab | 2021 | https://conductscience.org/library/papers/34496230 | PubMed |
| 6 | 35209221 | Synthesis of Copper Oxide-Based Nanoformulations of Etoricoxib and Montelukast and Their Evaluation through Analgesic, Anti-Inflammatory, Anti-Pyretic, and Acute Toxicity Activities. | Molecules | 2022 | https://conductscience.org/library/papers/35209221 | PubMed |
| 7 | 34685596 | Exosomes in the Tumor Microenvironment: From Biology to Clinical Applications. | Cells | 2021 | https://conductscience.org/library/papers/34685596 | PubMed |
| 8 | 36528193 | Hybrid exosomes, exosome-like nanovesicles and engineered exosomes for therapeutic applications. | J Control Release | 2023 | https://conductscience.org/library/papers/36528193 | PubMed |
| 9 | 11134944 | Crystallization of the yeast elongation factor complex eEF1A-eEF1B alpha. | Acta Crystallogr D Biol Crystallogr | 2001 | https://conductscience.org/library/papers/11134944 | PubMed |
| 10 | 35260831 | Challenges and directions in studying cell-cell communication by extracellular vesicles. | Nat Rev Mol Cell Biol | 2022 | https://conductscience.org/library/papers/35260831 | PubMed |
| 11 | 16618135 | Adhesion of antibody-functionalized polymersomes. | Langmuir | 2006 | https://conductscience.org/library/papers/16618135 | PubMed |
| 12 | 30359033 | Apple-Derived Nanoparticles Modulate Expression of Organic-Anion-Transporting Polypeptide (OATP) 2B1 in Caco-2 Cells. | Mol Pharm | 2018 | https://conductscience.org/library/papers/30359033 | PubMed |
| 13 | 26098775 | Citrus limon-derived nanovesicles inhibit cancer cell proliferation and suppress CML xenograft growth by inducing TRAIL-mediated cell death. | Oncotarget | 2015 | https://conductscience.org/library/papers/26098775 | PubMed |
| 14 | 27318094 | Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer. | Biomaterials | 2016 | https://conductscience.org/library/papers/27318094 | PubMed |
| 15 | 38059133 | Exosomes: Mediators of cellular communication in potentially malignant oral lesions and head and neck cancers. | F1000Res | 2023 | https://conductscience.org/library/papers/38059133 | PubMed |
| 16 | 36733407 | Angiopep-2 Modified Exosomes Load Rifampicin with Potential for Treating Central Nervous System Tuberculosis. | Int J Nanomedicine | 2023 | https://conductscience.org/library/papers/36733407 | PubMed |
| 17 | 34151426 | Plant-derived exosome-like nanoparticles: A concise review on its extraction methods, content, bioactivities, and potential as functional food ingredient. | J Food Sci | 2021 | https://conductscience.org/library/papers/34151426 | PubMed |
| 18 | 36196516 | Drug Value of Drynariae Rhizoma Root-Derived Extracellular Vesicles for Neurodegenerative Diseases Based on Proteomics and Bioinformatics. | Plant Signal Behav | 2022 | https://conductscience.org/library/papers/36196516 | PubMed |
| 19 | 34656117 | Extracellular vesicles: mediators of intercellular communication in tissue injury and disease. | Cell Commun Signal | 2021 | https://conductscience.org/library/papers/34656117 | PubMed |
| 20 | 34381015 | Decreased inhibition of exosomal miRNAs on SARS-CoV-2 replication underlies poor outcomes in elderly people and diabetic patients. | Signal Transduct Target Ther | 2021 | https://conductscience.org/library/papers/34381015 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42793979 | Fruit- and Vegetable-Derived Exosome-like Nanovesicles: A Review. | Foods | 2026 | https://conductscience.org/library/papers/42793979 | PubMed |
| 42371419 | Plant-derived extracellular vesicles for drug delivery: current and future. | Regen Biomater | 2026 | https://conductscience.org/library/papers/42371419 | PubMed |
| 42347955 | Unveiling the antifungal arsenal: proteomic profiling of tomato exosomes. | Planta | 2026 | https://conductscience.org/library/papers/42347955 | PubMed |
| 42292037 | Plant-Derived Exosome-Like Nanoparticles in Neurodegenerative Diseases: From Dual Bioactive-Delivery Roles to Translational Challenges. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42292037 | PubMed |
| 42014584 | Recent Progress in Exosome-Derived Nanocarriers for Breast Cancer Therapy: Advances, Translational Barriers, and Scale-Up Considerations. | Pharm Res | 2026 | https://conductscience.org/library/papers/42014584 | PubMed |
| 41471741 | Comparative Analysis of the Composition of Exosome-like Nanoparticles from Dried and Fresh Portulaca oleracea L. | Molecules | 2025 | https://conductscience.org/library/papers/41471741 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40573239
GET https://conductscience.org/api/papers/v1/40573239/references?page=2